Sequenom, Harvard University, Accelrys, Agilent, Nanogen, Ventana, Celera, Atria Genetics, Nanosphere | GenomeWeb
Sequenom Licenses Next-Gen Sequencing Technology from Harvard,
Launches Assay Design Service
 
Sequenom said this week that it has exclusively licensed technology from Harvard University that it will use to develop a nanopore-based sequencing platform that will be faster and cheaper than currently available technologies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.